Glen Santangelo
Stock Analyst at Barclays
Total Price Targets
27
Stocks Covered
17
Sectors
Healthcare, Technology
Most Recent
Mar 9, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Glen Santangelo
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| TALK | Talkspace, Inc. | $5.25 | $5.18 | +1.3% | 1 | Mar 9, 2026 |
| ALGN | Align Technology, Inc. | $200.00 | $178.47 | +12.1% | 1 | Feb 25, 2026 |
| IDXX | IDEXX Laboratories, Inc. | $800.00 | $568.78 | +40.7% | 2 | Feb 5, 2026 |
| GDRX | GoodRx Holdings, Inc. | $2.75 | $2.58 | +6.8% | 1 | Jan 22, 2026 |
| CAH | Cardinal Health, Inc. | $243.00 | $195.04 | +24.6% | 1 | Dec 8, 2025 |
| WAY | Waystar Holding Corp. | $42.00 | $21.23 | +97.8% | 1 | Dec 8, 2025 |
| DOCS | Doximity, Inc. | $63.00 | $25.02 | +151.7% | 1 | Dec 8, 2025 |
| BHC | Bausch Health Companies Inc. | $8.00 | $5.67 | +41.1% | 2 | Dec 8, 2025 |
| ALVO | Alvotech | $5.00 | $3.46 | +44.3% | 1 | Dec 8, 2025 |
| HQY | HealthEquity, Inc. | $134.00 | $82.71 | +62.0% | 2 | Sep 3, 2025 |
| XRAY | DENTSPLY SIRONA Inc. | $20.00 | $11.84 | +69.0% | 1 | Jan 23, 2025 |
| PGNY | Progyny, Inc. | $19.00 | $18.64 | +2.0% | 2 | Nov 13, 2024 |
| COLL | Collegium Pharmaceutical, Inc. | $40.00 | $34.18 | +17.0% | 2 | Nov 11, 2024 |
| PCRX | Pacira BioSciences, Inc. | $18.00 | $24.40 | -26.2% | 2 | Sep 24, 2024 |
| HIMS | Hims & Hers Health, Inc. | $18.00 | $27.22 | -33.9% | 3 | Aug 7, 2024 |
| VTRS | Viatris Inc. | $15.00 | $14.98 | +0.1% | 1 | Jul 19, 2024 |
| TDOC | Teladoc Health, Inc. | $10.00 | $6.48 | +54.3% | 3 | May 31, 2024 |
Recent Activity
- Mar 9, 2026— Set$5.25price target onTALK(Talkspace, Inc.)
- Feb 25, 2026— Set$200.00price target onALGN(Align Technology, Inc.)
- Feb 5, 2026— Set$800.00price target onIDXX(IDEXX Laboratories, Inc.)
- Jan 22, 2026— Set$2.75price target onGDRX(GoodRx Holdings, Inc.)
- Dec 8, 2025— Set$243.00price target onCAH(Cardinal Health, Inc.)
- Dec 8, 2025— Set$5.00price target onALVO(Alvotech)
- Dec 8, 2025— Set$63.00price target onDOCS(Doximity, Inc.)
- Dec 8, 2025— Set$42.00price target onWAY(Waystar Holding Corp.)
- Dec 8, 2025— Set$850.00price target onIDXX(IDEXX Laboratories, Inc.)
- Dec 8, 2025— Set$8.00price target onBHC(Bausch Health Companies Inc.)
- Sep 3, 2025— Set$134.00price target onHQY(HealthEquity, Inc.)
- Jan 23, 2025— Set$20.00price target onXRAY(DENTSPLY SIRONA Inc.)
- Nov 13, 2024— Set$19.00price target onPGNY(Progyny, Inc.)
- Nov 11, 2024— Set$40.00price target onCOLL(Collegium Pharmaceutical, Inc.)
- Sep 24, 2024— Set$18.00price target onPCRX(Pacira BioSciences, Inc.)
- Sep 19, 2024— Set$24.00price target onPGNY(Progyny, Inc.)
- Aug 7, 2024— Set$18.00price target onHIMS(Hims & Hers Health, Inc.)
- Jul 19, 2024— Set$15.00price target onVTRS(Viatris Inc.)
- Jun 13, 2024— Set$36.00price target onPCRX(Pacira BioSciences, Inc.)
- Jun 7, 2024— Set$44.00price target onCOLL(Collegium Pharmaceutical, Inc.)
Frequently Asked Questions
Who is Glen Santangelo?
Glen Santangelo is a stock analyst at Barclays covering 17 stocks primarily in Healthcare, Technology. They have issued 27 price targets since Feb 28, 2022.
What stocks does Glen Santangelo cover?
Glen Santangelo currently covers 17 stocks, including HIMS, TDOC, IDXX, BHC, HQY.
What is Glen Santangelo's latest price target?
Glen Santangelo's most recent price target was $5.25 on TALK (Talkspace, Inc.), set on Mar 9, 2026.
What is Glen Santangelo's highest price target?
Glen Santangelo's highest issued price target is $850.00 on IDXX, set on Dec 8, 2025.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.